When bone cancer is diagnosed, a carefully planned treatment approach becomes crucial for giving patients the best possible chance of recovery and maintaining quality of life.

How Treatment Goals Are Shaped for Bone Cancer Patients

The treatment of bone sarcoma, also called primary bone cancer, aims to remove or destroy cancer cells while preserving as much function and mobility as possible. Because bone cancer is rare and affects different age groups in different ways, the approach to treatment must be carefully tailored to each person’s unique situation. The main goals include eliminating the tumor, preventing it from spreading to other parts of the body such as the lungs, and helping patients return to active lives with the best possible physical function.^[1][2]

Treatment decisions depend heavily on several important factors. The type of bone cancer matters significantly, since osteosarcoma (the most common type), Ewing sarcoma, and chondrosarcoma each respond differently to various therapies. The location of the tumor within the body determines what surgical options are possible. The stage of cancer, meaning how large the tumor is and whether it has spread, plays a major role in planning treatment. The grade of the cancer, which describes how abnormal the cells look under a microscope, helps doctors predict how aggressively the tumor might grow. Finally, the patient’s age, overall health, and personal preferences all contribute to creating the most appropriate treatment plan.^[3][4]

Medical societies and cancer centers have established standard treatments that are widely accepted based on decades of research and clinical experience. These standard approaches have proven effective for many patients. At the same time, researchers continue to investigate new therapies through clinical trials, testing innovative drugs and treatment methods that may offer better outcomes or fewer side effects. Some patients may have the opportunity to participate in these trials, contributing to medical knowledge while potentially accessing treatments that are not yet widely available.^[5][6]

The journey through bone cancer treatment requires coordination among multiple specialists. A multidisciplinary team typically includes surgeons who specialize in bone tumors, medical oncologists who manage chemotherapy, radiation oncologists, pathologists who examine tissue samples, radiologists who interpret imaging tests, nurses specialized in cancer care, physical therapists, and sometimes prosthetists who create artificial limbs. This team approach ensures that all aspects of a patient’s care are addressed, from the medical treatment itself to rehabilitation and emotional support.^[14]

Standard Treatment Approaches for Bone Sarcoma

The cornerstone of bone cancer treatment has remained relatively consistent over several decades, with surgery and chemotherapy forming the primary approach for most patients. Understanding these standard treatments helps patients know what to expect and why certain methods are recommended.

Surgical Treatment

Surgery represents one of the most critical components of bone sarcoma treatment. The fundamental goal of surgery is to remove the entire tumor along with a margin of healthy tissue surrounding it, called the surgical margin. This margin helps ensure that no cancer cells are left behind that could potentially cause the disease to return.^[9][14]

For tumors located in the arms or legs, which is where most bone cancers occur, surgeons often perform what is called limb-sparing surgery or limb salvage surgery. This approach removes the affected bone and surrounding tissue while preserving the limb itself. After removing the cancerous bone, surgeons must reconstruct the area to maintain function. They may use a metal implant called a prosthesis, donor bone from a tissue bank called an allograft, or bone taken from another part of the patient’s own body called an autograft. In some cases, surgeons replace an entire joint with an artificial one, similar to hip or knee replacement surgery that older adults might receive for arthritis.^[7][15]

Modern surgical techniques have dramatically improved outcomes for bone cancer patients. Decades ago, amputation was the standard treatment for most bone cancers in the limbs. Today, between 90 and 95 percent of patients with bone cancer in their arms or legs can have their limbs saved through advanced surgical techniques. However, amputation is still necessary in some situations. This might be the case if the tumor has grown into major nerves or blood vessels, if the tumor is very large, or if the cancer returns after previous limb-sparing surgery. When amputation is performed, patients typically work with specialists to be fitted for an artificial limb that can help restore mobility and independence.^[9][12]

For cancers located in other bones, such as the pelvis, spine, or jaw, the surgical approach varies significantly. These operations can be quite complex because of the surrounding structures and the importance of these bones to the body’s support system. Surgeons with special expertise in bone cancer are essential for planning and performing these procedures.^[8]

If bone cancer has spread to the lungs, which is the most common site of spread, surgery may also be performed to remove these lung tumors. This is typically done through a wedge resection, where surgeons remove the tumor along with a small triangular section of lung tissue around it. Removing lung metastases can sometimes be done at the same time as the surgery on the primary bone tumor, or it may be performed later if tumors appear or return after initial treatment.^[15]

Chemotherapy

Chemotherapy uses powerful drugs to kill cancer cells throughout the body. For certain types of bone cancer, particularly osteosarcoma and Ewing sarcoma, chemotherapy is a standard and essential part of treatment. It works well for these cancers because the cancer cells are particularly sensitive to these drugs. However, chemotherapy is less effective for chondrosarcoma, which is why that type of bone cancer relies more heavily on surgery alone.^[11][14]

The timing of chemotherapy in bone cancer treatment follows a specific pattern. Patients typically receive chemotherapy before surgery, a phase called neoadjuvant chemotherapy. This preoperative treatment serves several purposes. It can shrink the tumor, making it easier to remove completely during surgery. It also begins attacking any cancer cells that may have already spread to other parts of the body but are too small to detect on scans. After surgery, patients usually continue with additional chemotherapy, called adjuvant chemotherapy. This post-surgery treatment aims to eliminate any remaining cancer cells and reduce the risk of the cancer returning.^[15][17]

For osteosarcoma, the most commonly used chemotherapy combination includes three drugs: high-dose methotrexate, doxorubicin, and cisplatin. This regimen is often referred to by the abbreviation MAP. Each of these drugs attacks cancer cells in different ways, making the combination more effective than any single drug alone. The treatment typically involves cycles spread over several months, with chemotherapy given before surgery taking about three months, and chemotherapy after surgery continuing for an additional six to nine months.^[15]

Other chemotherapy drugs that may be used for bone sarcoma include ifosfamide, etoposide, and carboplatin. The specific combination chosen depends on the type of bone cancer, how well the tumor responds to initial treatment, and the patient’s ability to tolerate side effects. For adults over age 40, doctors often use lower doses of methotrexate or different drug combinations because older adults tend to experience more severe side effects from high-dose methotrexate.^[15]

The side effects of chemotherapy can be significant and affect quality of life during treatment. Common side effects include nausea and vomiting, hair loss, increased risk of infections due to low white blood cell counts, fatigue, and mouth sores. Some chemotherapy drugs can affect specific organs. For example, doxorubicin can affect the heart, cisplatin can damage hearing or kidney function, and high-dose methotrexate can impact the liver and kidneys. Before starting chemotherapy, patients often undergo tests to establish baseline heart and kidney function. Throughout treatment, blood tests and other monitoring help doctors watch for side effects and adjust treatment if necessary.^[11]

For patients who will receive chemotherapy, additional preparations may be necessary. Many patients have a port placed, which is a device inserted under the skin that connects to a large vein. This port makes it easier to give chemotherapy and draw blood without repeated needle sticks. Young patients of childbearing age should discuss fertility preservation options with their oncologist before starting treatment, as some chemotherapy drugs can affect future fertility.^[8]

Radiation Therapy

Radiation therapy uses high-energy beams, similar to very powerful X-rays, to kill cancer cells. Unlike chemotherapy, which travels throughout the body, radiation is targeted to a specific area. For bone cancer, radiation therapy is not used as commonly as surgery and chemotherapy, but it plays an important role in certain situations.^[14][17]

Radiation therapy is particularly valuable for treating Ewing sarcoma. This type of bone cancer is quite sensitive to radiation, meaning the cancer cells are effectively killed by radiation treatment. For Ewing sarcoma, radiation may be used before or after surgery, depending on where the tumor is located and how easy it is to remove completely with surgery. In cases where surgery would be extremely difficult or would result in severe loss of function, such as tumors in the spine or pelvis, radiation therapy might be used as the primary treatment instead of surgery.^[14][16]

For osteosarcoma and chondrosarcoma, radiation therapy is less commonly used because these cancers are less sensitive to radiation. However, radiation might still be recommended if the tumor cannot be completely removed with surgery, if the cancer has spread to areas where surgery is not possible, or to help control pain and other symptoms in advanced cases.^[14]

Radiation treatment is typically given five days a week for several weeks, though the exact schedule depends on the specific situation. Each treatment session is painless and lasts only a few minutes, though patients need to lie still during the treatment. Side effects of radiation therapy depend on the area being treated. Skin in the treatment area may become red, dry, or irritated, similar to a sunburn. Fatigue is common during radiation treatment. If radiation is given near the digestive system, nausea may occur. Long-term side effects can include changes in bone growth in children, increased risk of fractures in the treated bone, and rarely, the development of a second cancer many years after treatment.^[17]

Targeted Therapy

Targeted medicines represent a newer approach to cancer treatment. Unlike chemotherapy, which affects all rapidly dividing cells in the body, targeted drugs are designed to interfere with specific molecules involved in cancer growth and spread. For bone sarcoma, targeted therapies are used in select cases and are not yet standard treatment for all patients.^[14]

The use of targeted therapy depends on several factors including the specific type of bone cancer, the size and stage of the tumor, how the cancer responds to other treatments, and the patient’s overall health. Some targeted medicines may be given alone, while others are used in combination with chemotherapy. These drugs are typically considered when standard treatments have not worked well or when the cancer has returned after initial treatment.^[14]

Innovative Treatments Being Studied in Clinical Trials

While standard treatments for bone sarcoma have not changed dramatically in over 40 years, researchers are actively investigating new approaches through clinical trials. These studies test whether new drugs, new combinations of existing treatments, or entirely novel therapies might improve outcomes for patients with bone cancer.

Understanding Clinical Trial Phases

Clinical trials follow a structured process divided into phases, each designed to answer specific questions about a new treatment. Phase I trials focus primarily on safety, testing a new treatment in a small group of people to determine the appropriate dose and identify side effects. Phase II trials expand to a larger group of patients to begin evaluating whether the treatment is effective against the cancer while continuing to monitor safety. Phase III trials compare the new treatment directly against the current standard treatment in a large group of patients, providing the strongest evidence about whether the new approach is better, worse, or equivalent to existing options.^[13]

Novel Therapeutic Approaches

Research into osteosarcoma and other bone sarcomas explores multiple avenues for improving treatment. Understanding the basic biology of bone formation has helped scientists identify potential targets for new therapies. Normal bone development involves complex interactions between different types of cells and numerous molecular signals. When these processes go wrong, cancer can develop. By targeting the specific abnormal pathways in cancer cells, researchers hope to create treatments that are more effective and cause fewer side effects than traditional chemotherapy.^[13]

Some research focuses on immunotherapy, which harnesses the power of the patient’s own immune system to fight cancer. The immune system normally identifies and destroys abnormal cells, but cancer cells can develop ways to hide from or suppress the immune response. Immunotherapy drugs work by removing these barriers, allowing the immune system to recognize and attack cancer cells more effectively. While immunotherapy has shown remarkable success in some types of cancer, research is still ongoing to determine how best to use these approaches for bone sarcoma.^[13]

Another area of investigation involves drugs that target specific molecules or pathways that cancer cells need to grow and survive. Scientists have identified various proteins and enzymes that are abnormally active in bone cancer cells. Drugs designed to block these specific targets could potentially stop tumor growth while causing less damage to normal cells compared to traditional chemotherapy. Clinical trials are testing various targeted drugs, often identified by code names or numbers during early development, to see if they can improve outcomes for bone sarcoma patients.^[13]

Researchers are also investigating better ways to use existing chemotherapy drugs. This includes testing different combinations of drugs, different dosing schedules, and different sequences of treatment. Some trials explore whether adding newer drugs to standard chemotherapy regimens might improve results for patients whose cancers are at high risk of spreading or returning.^[13]

Eligibility and Participation in Clinical Trials

Clinical trials for bone sarcoma are conducted at specialized cancer centers in various locations including the United States, Europe, and other regions around the world. Each trial has specific eligibility criteria that determine who can participate. These criteria typically consider factors such as the type and stage of cancer, previous treatments received, age, and overall health status. Some trials are specifically designed for newly diagnosed patients, while others focus on patients whose cancer has returned or has not responded to standard treatment.^[8]

Patients interested in participating in a clinical trial should discuss this option with their oncologist. The medical team can help identify trials that might be appropriate and explain the potential benefits and risks. Participating in a clinical trial gives patients access to new treatments that are not yet widely available and contributes to advancing medical knowledge that may help future patients. However, participation is voluntary, and patients can continue with standard treatment if they prefer not to enroll in a trial.^[10]

Most common treatment methods

• Surgery
  • Wide resection to remove the tumor along with surrounding healthy tissue margin
  • Limb-sparing surgery (limb salvage) to preserve arms or legs affected by cancer
  • Reconstruction using metal implants (prostheses), donor bone (allograft), or patient’s own bone (autograft)
  • Joint replacement with artificial joints for tumors near knee, hip, or shoulder
  • Amputation when tumor involves nerves or blood vessels or when limb salvage is not feasible
  • Metastasectomy to remove cancer that has spread to lungs
• Chemotherapy
  • Neoadjuvant chemotherapy given before surgery to shrink tumors
  • Adjuvant chemotherapy given after surgery to eliminate remaining cancer cells
  • MAP regimen for osteosarcoma (high-dose methotrexate, doxorubicin, cisplatin)
  • Alternative drug combinations including ifosfamide, etoposide, and carboplatin
  • Modified doses for adults over 40 to reduce severe side effects
  • Treatment for advanced or metastatic bone cancer to slow growth and control symptoms
• Radiation Therapy
  • Primary treatment for Ewing sarcoma, especially when surgery is not feasible
  • Used before or after surgery for Ewing sarcoma depending on tumor location
  • Treatment for tumors in spine, pelvis, or other difficult-to-operate locations
  • Symptom control for pain and complications in advanced bone cancer
• Targeted Therapy
  • Drugs that interfere with specific molecules involved in cancer growth
  • Used alone or in combination with chemotherapy
  • Considered when standard treatments have not worked or cancer has returned
  • Selected based on cancer type, stage, previous treatments, and overall health
• Clinical Trial Treatments
  • Immunotherapy drugs to enhance immune system recognition of cancer cells
  • Novel targeted drugs blocking specific proteins and enzymes in cancer cells
  • New combinations and sequences of existing chemotherapy drugs
  • Gene therapy and other innovative molecular approaches under investigation